X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DRUGS IN R&D

期刊標題檢索 最新評論: 沒有評論


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DRUGS IN R&D]您好,您是該頁面的第 12548 位訪客。

期刊簡介
期刊名稱DRUGS IN R&D DRUGS IN R&D
LetPub Score
4.9
50 ratings
Rate

Reputation
5.9

Influence
3.8

Speed
7.0

期刊簡稱DRUGS R&D
ISSN1174-5886
E-ISSN1179-6901
h-index39
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.100.7080.837
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q2151 / 313

自引率 (2023-2024)4.50%自引率趨勢
掲載範囲
Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.

The Journal includes:

Clinical research on new and established drugs;
Preclinical research of direct relevance to clinical drug development;
Short communications and case study reports that meet the above criteria will also be considered;
Reviews may also be considered.
官方網站https://www.springer.com/40268
在線稿件提交https://www.editorialmanager.com/drda
開放訪問Yes
出版商Springer International Publishing
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區New Zealand
發行頻率年4回刊行(2010年~)
創刊年1999
每年文章數37每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP2390; USD3490; EUR2790; )
APC waiver:Check Notes
Other charges: No
Keywords: pharmacology、drug development
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ3204/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1174-5886%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 8 Weeks
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【DRUGS IN R&D】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    VaccinesH-index: 0

    CiteScore: 8.90
    Diabetes Metabolic Syndrome and ObesityH-index: 35

    CiteScore: 5.90
    INDIAN JOURNAL OF PHARMACOLOGYH-index: 0

    CiteScore: 4.00
    Contemporary Clinical Trials CommunicationsH-index: 0

    CiteScore: 2.70
    BULLETIN OF PHARMACEUTICAL SCIENCESH-index: 0

    CiteScore: 0.40
    Journal of Jilin University Medicine EditionH-index: 0

    CiteScore: 0.20
    Antiviral Chemistry and ChemotherapyH-index: 0

    CiteScore: 5.20
    Current Pharmacogenomics and Personalized MedicineH-index: 0

    CiteScore: 0.40
    Advances in PharmacologyH-index: 0

    CiteScore: 9.10
    Chinese Journal of Cancer BiotherapyH-index: 0

    CiteScore: 0.20
    學科內最受檢索的期刊 頁面查看次數
    Contemporary Clinical Trials Communications243018
    Vaccines49894
    Diabetes Metabolic Syndrome and Obesity36151
    INDIAN JOURNAL OF PHARMACOLOGY9265
    BULLETIN OF PHARMACEUTICAL SCIENCES8091
    Current Pharmacogenomics and Personalized Medicine3388
    Biomedical and Pharmacology Journal3221
    Advances in Pharmacology3072
    Infectious Disorders - Drug Targets2304
    Anti-Infective Agents2208
  •  

    DRUGS IN R&D DRUGS IN R&D
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    下一頁    末頁  (0/0)
  [DRUGS IN R&D] 的評論撰寫評論
暫無評論。
首頁    上一頁    下一頁    末頁  (0/0)

開始撰寫 [DRUGS IN R&D] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*